Skip Nav Destination
Entry Threats and Pricing in the Generic Drug Industry
The Review of Economics and Statistics (2014) 96 (2): 214–228.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Tom‐Reiel Heggedal
- Leif Helland
- Espen R. Moen
International Economic Review (2024) 65 (2): 693.
- Steven W. Landgraf
Telecommunications Policy (2023) 47 (10): 102671.
- Ivan Lugovoi
- Dimitrios A. Andritsos
- Claire Senot
Manufacturing & Service Operations Management (2022) 24 (3): 1760.
- Cici McNamara
- Natalia Serna
Health Economics (2022) 31 (11): 2311.
- Bill Hu
- Joon Ho Hwang
- Christine Jiang
- Jim Washam
- Li Zeng
Finance Research Letters (2022) 46: 102357.
- Germán Bet
International Journal of Industrial Organization (2021) 75: 102705.
- RICHARD G. FRANK
- THOMAS G. MCGUIRE
- IAN NASON
The Milbank Quarterly (2021) 99 (3): 828.
- Victoria Serra-Sastre
- Simona Bianchi
- Jorge Mestre-Ferrandiz
- Phill O’Neill
The European Journal of Health Economics (2021) 22 (2): 229.
- Jon A. Garfinkel
- Mosab Hammoudeh
SSRN Electronic Journal (2020)
- Daniel Hosken
- David Schmidt
- Matthew C. Weinberg
The Journal of Industrial Economics (2020) 68 (1): 1.
- Kirk W. Kerr
- Lukas J. Glos
Pharmaceutical Medicine (2020) 34 (1): 19.
- J. M. Binner
- F. Ciardiello
- L. R. Fletcher
- V. N. Kolokoltsov
International Game Theory Review (2019) 21 (02): 1940007.
- Luke M. Olson
- Brett W. Wendling
Review of Industrial Organization (2018) 53 (1): 139.
- Cathy Ge Bao
- Maggie Xiaoyang Chen
American Economic Journal: Applied Economics (2018) 10 (4): 120.
- Shraddha Chakradhar
- Roxanne Khamsi
Nature Medicine (2017) 23 (10): 1114.
- Daniel S. Hosken
- Luke M. Olson
- Loren K. Smith
Economic Inquiry (2016) 54 (1): 342.